Skip navigation

Manage Cost, Expand Access, Improve Patient Services and Care Delivery for Specialty and Rare Disease Therapies

January 25-26, 2018
  • Las Vegas, NV

CBI’s Specialty Therapies 2018 — A Forum for Payers convenes health plans, PBMs, pharmacies and pharmaceutical companies to share timely innovation for managing specialty and rare disease therapies.

ROBUST AGENDA PROVIDES OPPORTUNITY TO
TAILOR YOUR LEARNING EXPERIENCE

  • Understand how pharmacies leverage networks to provide medications they may not have access to
  • Learn key concepts to assist your plan in getting the most out of
    your 340B pharmacy relationships
  • Hear a Washington Update on changes to the Affordable Care Act
  • Latest advancements in integrating the medical and pharmacy benefit
  • Take a deep dive into site-of-care optimization
  • Establish tools to manage utilization such as ePrior Authorizations and formulary exclusions
  • Review the importance of a quality insurance verification and benefit investigation of your patients and how that impacts the access, economics and maintenance of their Oral Oncolytic Prescription
  • Examine real world therapy management program response
    to PCSK9 medications
  • Adapt programs and value-based design strategies to manage the high costs of pharmaceuticals
  • Identify trends in formulary design
  • Analyze the biosimilars pipeline and anticipate access barriers
  • Compare drug channels for rare disease therapies
  • Discuss trends in orphan drug FDA approval and pipeline

Previous Attendee Acclaim:

Class act!

Director of Specialty Pharmacy Programs, Blue Cross Blue Shield South Carolina

I found the program to be well-designed and stimulating,
well worth my time.

Executive Director, MidAtlantic Business Group on Health

The specialty pharmacy arena is constantly evolving. Quality Conferences like CBI’s Specialty Therapies Forum for Payers allows payers and industry alike to hear from KOL’s and
prepare for the challenges that they are currently dealing
with or will be facing in the near future.

Director, Clinical Pharmacy, Blue Cross Blue Shield of Tennessee

The conference provided a unique insight into the payer viewpoint and allowed attendees to observe complex discussions between interested parties.

Manager of Specialty Clinical Services, Fairview Specialty Pharmacy

January 25-26, 2018 | Las Vegas, NV

Specialty Therapies 2018 — A Forum for Payers

Manage Cost, Expand Access, Improve Patient Services and Care Delivery for Specialty and Rare Disease Therapies

CBI’s Specialty Therapies 2018 — A Forum for Payers convenes health plans, PBMs, pharmacies and pharmaceutical companies to share timely innovation for managing specialty and rare disease therapies.

ROBUST AGENDA PROVIDES OPPORTUNITY TO
TAILOR YOUR LEARNING EXPERIENCE

  • Understand how pharmacies leverage networks to provide medications they may not have access to
  • Learn key concepts to assist your plan in getting the most out of
    your 340B pharmacy relationships
  • Hear a Washington Update on changes to the Affordable Care Act
  • Latest advancements in integrating the medical and pharmacy benefit
  • Take a deep dive into site-of-care optimization
  • Establish tools to manage utilization such as ePrior Authorizations and formulary exclusions
  • Review the importance of a quality insurance verification and benefit investigation of your patients and how that impacts the access, economics and maintenance of their Oral Oncolytic Prescription
  • Examine real world therapy management program response
    to PCSK9 medications
  • Adapt programs and value-based design strategies to manage the high costs of pharmaceuticals
  • Identify trends in formulary design
  • Analyze the biosimilars pipeline and anticipate access barriers
  • Compare drug channels for rare disease therapies
  • Discuss trends in orphan drug FDA approval and pipeline

Previous Attendee Acclaim:

Class act!

Director of Specialty Pharmacy Programs, Blue Cross Blue Shield South Carolina

I found the program to be well-designed and stimulating,
well worth my time.

Executive Director, MidAtlantic Business Group on Health

The specialty pharmacy arena is constantly evolving. Quality Conferences like CBI’s Specialty Therapies Forum for Payers allows payers and industry alike to hear from KOL’s and
prepare for the challenges that they are currently dealing
with or will be facing in the near future.

Director, Clinical Pharmacy, Blue Cross Blue Shield of Tennessee

The conference provided a unique insight into the payer viewpoint and allowed attendees to observe complex discussions between interested parties.

Manager of Specialty Clinical Services, Fairview Specialty Pharmacy

January 25-26, 2018 | Las Vegas, NV